Study: Medications For Fighting Cancer Can Help In Battling Antibiotic Resistance

Recommend to others!

Cancer has been one of the most fatal diseases, in the history of health care. This can cause a lot of burden not only physically but also psychologically and emotionally to the affected person. More so, it affects the family, as it can also bring financial burdens. Nonetheless, cancer therapies are continuously being developed in order to save more lives worldwide. On the other end, as much as anti-cancer drugs are being studied, studies have been conducted too to answer the problem of antibiotic resistance. This kind of drug resistance serves as a compelling concern for many patients with infectious diseases. As of the moment, most of the world’s populations are also suffering from serious illnesses caused by hazardous, constantly evolving microorganisms.

In this regard, a new study, published in Chemistry & Biology, was initiated by Gerry Wright, scientific director of the Michael G. DeGroote Institute for Infectious Disease Research at McMaster University. According to the research, medications utilized against cancer may be used to fight antibiotic resistance. Wright stated that their study revealed that particular proteins, known as kinases, that render antibiotic resistance are connected structurally with proteins essential in cancer.

Furthermore, Wright elaborated that a great investment was done by the pharmaceutical industry by focusing in these proteins. Indeed, there are several drugs and compounds existing in the pharmaceutical arena that can be explored with new perspective and can possibly be utilized to respond to the concern of resistant antibiotics. Moreover, testing 14 antibiotic resistant molecules versus 80 chemically varied protein kinase inhibitors is entailed in this broad-scale study.

Antibiotic resistance has been a rising problem all over the world because a greater number of viruses have overpowered the antibiotics presently available. Wright expressed how significant and urgent it is to develop novel medications and antibiotic approaches in order to contribute in controlling infectious diseases. He further hoped that investigations in the future about combination treatments can bring more light in the context of antibiotic resistance.

Moreover, Wright stated that the inadequacy of new chemical gallows with antibiotic activity is among the odds that need to be responded to by the drug discovery community. He further added that this issue has resulted to the open query about the “low-hanging fruit”, whether every simple implementable antibiotic chemical gallows have already been taken advantaged in the last five decades.

Indeed, there are still much to be known and understood in finding the answer about antibiotic resistance. However, this study can contribute in establishing the ground works associating anti-cancer drugs with combating antibiotic resistance.




Speak Your Mind


Current day month ye@r *